Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-γ-knockout mice

被引:32
作者
Afanasyeva, M
Georgakopoulos, D
Fairweather, D
Caturegli, P
Kass, DA
Rose, NR
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
关键词
cardiac output; pressure-volume relation; hemodynamics; inflammation; myocarditis;
D O I
10.1161/01.CIR.0000147538.92263.3A
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Constrictive pericarditis represents a serious hemodynamic syndrome that may lead to heart failure. Studies of its pathophysiological mechanisms have been impeded by the lack of an animal model. Methods and Results - Cardiac myosin - induced experimental autoimmune myocarditis in interferon (IFN)-gamma-knockout ( KO) mice results in increased cardiac inflammation and development of severe grossly detectable pericarditis. Using in vivo pressure-volume studies, we found that the acute phase of experimental autoimmune myocarditis in IFN-gamma-KO mice was characterized by reduced left ventricular (LV) volumes compared with wild-type mice. The KO mice exhibited a classic restrictive/constrictive phenotype with decreased cardiac output, increased chamber stiffness, preserved ejection fraction, and impaired diastolic filling, characterized by reduced deceleration time and pressure tracings showing the square root sign similar to that observed in clinical cases of constrictive pericarditis. This phenotype was not associated with the severity of myocarditis but correlated with the presence of grossly detectable adhesive pericarditis present only in the KO group and characterized by increased pericardial inflammation and fibrosis. Comparison of IFN-gamma-KO and wild-type mice matched for the severity of myocardial disease further confirmed that pericarditis, and not myocarditis, was responsible for smaller LV volumes, reduced cardiac output, increased cardiac stiffness, and increased peak filling rate adjusted for end-diastolic volumes in KO mice. Conclusions - Autoimmune heart disease in IFN-gamma-KO mice results in increased pericardial inflammation and fibrosis, leading to constrictive phenotype during the acute phase of disease. It represents a novel animal model of constrictive pericarditis.
引用
收藏
页码:2910 / 2917
页数:8
相关论文
共 23 条
  • [1] Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-γ-independent pathway
    Afanasyeva, M
    Wang, Y
    Kaya, Z
    Stafford, EA
    Dohmen, KM
    Akha, AAS
    Rose, NR
    [J]. CIRCULATION, 2001, 104 (25) : 3145 - 3151
  • [2] Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype
    Afanasyeva, M
    Wang, Y
    Kaya, Z
    Park, S
    Zilliox, MJ
    Schofield, BH
    Hill, SL
    Rose, NR
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) : 193 - 203
  • [3] Ando M, 1999, Respirology, V4, P383, DOI 10.1046/j.1440-1843.1999.00209.x
  • [4] Synergy between CD40 Ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling
    Atamas, SP
    Luzina, IG
    Dai, HQ
    Wilt, SG
    White, B
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (03) : 1139 - 1145
  • [5] Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis
    Chiaramonte, MG
    Cheever, AW
    Malley, JD
    Donaldson, DD
    Wynn, TA
    [J]. HEPATOLOGY, 2001, 34 (02) : 273 - 282
  • [6] GAMMA-INTERFERON IS THE LYMPHOKINE AND BETA-INTERFERON THE MONOKINE RESPONSIBLE FOR INHIBITION OF FIBROBLAST COLLAGEN PRODUCTION AND LATE BUT NOT EARLY FIBROBLAST PROLIFERATION
    DUNCAN, MR
    BERMAN, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (02) : 516 - 527
  • [7] Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart
    Georgakopoulos, D
    Kass, DA
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2001, 534 (02): : 535 - 545
  • [8] Pericardial diseases
    Samer S. Kabbani
    Martin M. Le Winter
    [J]. Current Treatment Options in Cardiovascular Medicine, 2002, 4 (6) : 487 - 495
  • [9] Kabbani Samer S., 2000, Cardiology Clinics, V18, P501, DOI 10.1016/S0733-8651(05)70158-2
  • [10] Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis
    Kalra, S
    Utz, JP
    Ryu, JH
    [J]. MAYO CLINIC PROCEEDINGS, 2003, 78 (09) : 1082 - 1087